RecruitingACTRN12611000504910

A prospective longitudinal cohort study describing quality of life in patients undergoing pulmonary metastasectomy for metastatic sarcoma


Sponsor

Australasian Sarcoma Study Group (ASSG)

Enrollment

140 participants

Start Date

Apr 20, 2011

Study Type

Observational

Conditions

Summary

Evaluate the Health Related Quality of Life (HRQOL) associated with pulmonary metastasectomy (PM) (specifically: dyspnoea, cough, chest pain, pain interference, fatigue, physical functioning, role functioning, social functioning, satisfaction with social discretionary activities and satisfaction with social roles, emotional functioning, depression, anxiety and overall HRQOL).


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study follows people with sarcoma — a type of cancer that starts in bones or soft tissues — who have cancer that has spread to the lungs and are having surgery to remove those lung tumours (called pulmonary metastasectomy). The goal is to understand how this surgery affects quality of life, including symptoms like breathlessness, fatigue, pain, and emotional wellbeing, so that doctors and patients can make better decisions together. You may be eligible if: - You are 18 years of age or older - You have been diagnosed with metastatic bone or soft tissue sarcoma - The cancer has spread only to your lungs (not other organs) - You are planning to have surgery to remove the lung tumours - You are able to provide signed informed consent You may NOT be eligible if: - There are no specific exclusion criteria listed for this study Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

No intervention, Quality of Life Study. Patients undergoing a PM for metastatic sarcoma will be invited to complete HRQOL Assessments prior to their surgery and at certain time points after their sur

No intervention, Quality of Life Study. Patients undergoing a PM for metastatic sarcoma will be invited to complete HRQOL Assessments prior to their surgery and at certain time points after their surgery for up to three years after their PM surgery.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000504910